Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy.


Journal

Molecular medicine reports
ISSN: 1791-3004
Titre abrégé: Mol Med Rep
Pays: Greece
ID NLM: 101475259

Informations de publication

Date de publication:
07 2020
Historique:
received: 27 11 2019
accepted: 19 03 2020
pubmed: 8 5 2020
medline: 17 2 2021
entrez: 8 5 2020
Statut: ppublish

Résumé

Mammalian STE20-like kinase 1 (MST1) plays an important role in pancreatic cancer progression, but its downstream targets are still unknown. In the present study, our results indicated that MST1 expression was significantly downregulated in pancreatic cancer cell lines (PANC‑1, BxPC‑3 and HPAC) compared with that in the normal ductal epithelial cell line (hTERT‑HPNE). Moreover, MST1 overexpression in PANC‑1 cells led to increased apoptosis as determined by MTT and TUNEL assays and inhibited cellular migration. Mechanistically, upregulation of MST1 expression caused mitochondrial dysfunction, decreased ATP production, and activation of the mitochondrial‑dependent apoptotic pathway via inhibition of mitofusin 2 (Mfn2)‑mediated mitophagy, which ultimately resulted in increased cellular apoptosis and decreased cellular migration. Collectively, the present study demonstrated that MST1 may regulate pancreatic cancer PANC‑1 cell survival, invasion and migration through Mfn2‑mediated mitophagy, laying the foundation for the exploration of novel therapeutic targets for pancreatic cancer.

Identifiants

pubmed: 32377725
doi: 10.3892/mmr.2020.11098
pmc: PMC7248474
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
Mitochondrial Proteins 0
STK4 protein, human EC 2.7.1.11
Protein Serine-Threonine Kinases EC 2.7.11.1
GTP Phosphohydrolases EC 3.6.1.-
MFN2 protein, human EC 3.6.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

398-404

Références

Neurochem Res. 2018 Oct;43(10):1963-1977
pubmed: 30136162
Chemotherapy. 2016;61(6):304-12
pubmed: 27100100
Nat Commun. 2015 Oct 05;6:8357
pubmed: 26437443
J Biol Chem. 2018 Sep 21;293(38):14891-14904
pubmed: 30087121
Biochem Biophys Res Commun. 2018 Jan 1;495(1):60-63
pubmed: 29107692
Oncol Rep. 2018 Apr;39(4):1671-1681
pubmed: 29436693
Mol Cancer. 2017 Feb 28;16(1):52
pubmed: 28245823
Mol Med Rep. 2018 Jan;17(1):284-292
pubmed: 29115599
Biochem Pharmacol. 2018 Feb;148:100-110
pubmed: 29277693
World J Gastroenterol. 2016 Nov 28;22(44):9694-9705
pubmed: 27956793
J Cell Mol Med. 2018 Oct;22(10):5132-5144
pubmed: 30063115
World J Gastroenterol. 2015 Jul 14;21(26):7988-8003
pubmed: 26185370
Cell Biol Toxicol. 2018 Aug;34(4):263-277
pubmed: 29063978
J Physiol Sci. 2019 Jan;69(1):113-127
pubmed: 29961191
Oncol Lett. 2019 Dec;18(6):6752-6758
pubmed: 31807184
Nat Commun. 2017 Feb 01;8:14275
pubmed: 28145433
Int J Cancer. 2017 Jul 15;141(2):231-241
pubmed: 28240774
J Biol Chem. 2018 Sep 14;293(37):14455-14469
pubmed: 30072378
Curr Med Chem. 2018;25(40):5597-5612
pubmed: 28618992
Sci Rep. 2013;3:1870
pubmed: 23694968
Crit Rev Oncol Hematol. 2017 Jun;114:139-152
pubmed: 28477742
Nat Chem Biol. 2017 Jan 19;13(2):136-146
pubmed: 28103219
Mol Cancer Res. 2017 Aug;15(8):1029-1039
pubmed: 28373289
J Mol Cell Cardiol. 2018 Jan;114:141-149
pubmed: 29155025
Redox Biol. 2018 Jun;16:157-168
pubmed: 29502045
J Exp Clin Cancer Res. 2018 Oct 16;37(1):250
pubmed: 30326943
Sci Rep. 2017 Jul 27;7(1):6656
pubmed: 28751712
EMBO J. 2016 Aug 1;35(15):1677-93
pubmed: 27334614
Essays Biochem. 2017 Dec 12;61(6):687-697
pubmed: 29233878
Biochem Biophys Res Commun. 2017 Jan 15;482(3):432-439
pubmed: 28212727
Cell Physiol Biochem. 2018;45(3):1172-1190
pubmed: 29448246
Oncogene. 2017 Mar;36(10):1315-1327
pubmed: 27593930
Anticancer Res. 2017 Jun;37(6):2761-2775
pubmed: 28551612
Future Oncol. 2016 Aug;12(16):1929-46
pubmed: 27246628
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cell Rep. 2017 Sep 19;20(12):2846-2859
pubmed: 28930681
Diabetologia. 2016 Nov;59(11):2435-2447
pubmed: 27510910
Cell Mol Biol Lett. 2018 May 8;23:21
pubmed: 29760744
Clin Exp Med. 2019 May;19(2):211-218
pubmed: 30673917
J Cell Mol Med. 2017 Sep;21(9):2055-2067
pubmed: 28244691
Mol Cancer Res. 2019 Jun;17(6):1316-1325
pubmed: 30796177
J Pineal Res. 2017 Sep;63(2):
pubmed: 28480597
World J Gastroenterol. 2016 Jan 14;22(2):790-800
pubmed: 26811625
Oncotarget. 2017 Mar 7;8(10):16356-16366
pubmed: 28099921

Auteurs

Yongli Hu (Y)

Department of Gastrointestinal Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China.

Bing Wang (B)

Department of General Surgery, 900th Hospital of the Joint Service Support Force of the PLA, Fuzhou, Fujian 350000, P.R. China.

Lie Wang (L)

Department of General Surgery, 900th Hospital of the Joint Service Support Force of the PLA, Fuzhou, Fujian 350000, P.R. China.

Zhenran Wang (Z)

Department of Gastrointestinal Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China.

Zhiyuan Jian (Z)

Department of Gastrointestinal Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, P.R. China.

Lin Deng (L)

Department of General Surgery, 900th Hospital of the Joint Service Support Force of the PLA, Fuzhou, Fujian 350000, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH